These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 18430130)
1. New dosing strategies for liposomal amphotericin B in high-risk patients. Ellis M Clin Microbiol Infect; 2008 May; 14 Suppl 4():55-64. PubMed ID: 18430130 [TBL] [Abstract][Full Text] [Related]
2. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B. Smith PJ; Olson JA; Constable D; Schwartz J; Proffitt RT; Adler-Moore JP J Antimicrob Chemother; 2007 May; 59(5):941-51. PubMed ID: 17400589 [TBL] [Abstract][Full Text] [Related]
3. Use of liposomal amphotericin B in bone marrow transplant. Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256 [TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Ullmann AJ; Bouza E; Heussel CP; Lortholary O; Rieger C; Boehme A; Aoun M; Horst HA; Thiebaut A; Ruhnke M; Reichert D; Vianelli N; Krause SW; Olavarria E; Herbrecht R; Clin Infect Dis; 2007 May; 44(10):1289-97. PubMed ID: 17443465 [TBL] [Abstract][Full Text] [Related]
5. Lipid formulations of amphotericin B. Dix SP; Andriole VT Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516 [TBL] [Abstract][Full Text] [Related]
6. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial]. Rieger CT; Dittmer M; Ostermann H Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499 [TBL] [Abstract][Full Text] [Related]
7. Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data. Muñoz P; Guinea J; Narbona MT; Bouza E Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S125-31. PubMed ID: 19013336 [TBL] [Abstract][Full Text] [Related]
8. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. Khan MA; Owais M J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592 [TBL] [Abstract][Full Text] [Related]
9. Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety. Monforte V; Ussetti P; López R; Gavaldà J; Bravo C; de Pablo A; Pou L; Pahissa A; Morell F; Román A J Heart Lung Transplant; 2009 Feb; 28(2):170-5. PubMed ID: 19201343 [TBL] [Abstract][Full Text] [Related]
10. Amphotericin B lipid preparations: what are the differences? Adler-Moore JP; Proffitt RT Clin Microbiol Infect; 2008 May; 14 Suppl 4():25-36. PubMed ID: 18430127 [TBL] [Abstract][Full Text] [Related]
11. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation. Monforte V; Ussetti P; Gavaldà J; Bravo C; Laporta R; Len O; García-Gallo CL; Tenorio L; Solé J; Román A J Heart Lung Transplant; 2010 May; 29(5):523-30. PubMed ID: 20061165 [TBL] [Abstract][Full Text] [Related]
12. Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis. Adler-Moore JP; Olson JA; Proffitt RT J Antimicrob Chemother; 2004 Dec; 54(6):1096-102. PubMed ID: 15509617 [TBL] [Abstract][Full Text] [Related]
13. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections. Hooshmand-Rad R; Reed MD; Chu A; Gotz V; Morris JA; Weinberg J; Dominguez EA Clin Ther; 2004 Oct; 26(10):1652-62. PubMed ID: 15598482 [TBL] [Abstract][Full Text] [Related]
14. Liposomal amphotericin B: what is its role in 2008? Lanternier F; Lortholary O Clin Microbiol Infect; 2008 May; 14 Suppl 4():71-83. PubMed ID: 18430132 [TBL] [Abstract][Full Text] [Related]
15. Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study. Cordonnier C; Mohty M; Faucher C; Pautas C; Robin M; Vey N; Monchecourt F; Mahi L; Ribaud P Int J Antimicrob Agents; 2008 Feb; 31(2):135-41. PubMed ID: 18162375 [TBL] [Abstract][Full Text] [Related]
16. The role of liposomal amphotericin B in the treatment of systemic fungal infections. Patterson TF; Andriole VT Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S63-8. PubMed ID: 2693111 [TBL] [Abstract][Full Text] [Related]
18. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation. Shah T; Lai WK; Gow P; Leeming J; Mutimer D Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401 [TBL] [Abstract][Full Text] [Related]
19. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients]. López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227 [TBL] [Abstract][Full Text] [Related]